151 related articles for article (PubMed ID: 19562736)
1. Estimation of absolute risk for prostate cancer using genetic markers and family history.
Xu J; Sun J; Kader AK; Lindström S; Wiklund F; Hsu FC; Johansson JE; Zheng SL; Thomas G; Hayes RB; Kraft P; Hunter DJ; Chanock SJ; Isaacs WB; Grönberg H
Prostate; 2009 Oct; 69(14):1565-72. PubMed ID: 19562736
[TBL] [Abstract][Full Text] [Related]
2. Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer.
Sun J; Kader AK; Hsu FC; Kim ST; Zhu Y; Turner AR; Jin T; Zhang Z; Adolfsson J; Wiklund F; Zheng SL; Isaacs WB; Grönberg H; Xu J
Prostate; 2011 Mar; 71(4):421-30. PubMed ID: 20878950
[TBL] [Abstract][Full Text] [Related]
3. Prostate genetic score (PGS-33) is independently associated with risk of prostate cancer in the PLCO trial.
Liss MA; Xu J; Chen H; Kader AK
Prostate; 2015 Sep; 75(12):1322-8. PubMed ID: 25982801
[TBL] [Abstract][Full Text] [Related]
4. Homeobox B13 G84E Mutation and Prostate Cancer Risk.
Nyberg T; Govindasami K; Leslie G; Dadaev T; Bancroft E; Ni Raghallaigh H; Brook MN; Hussain N; Keating D; Lee A; McMahon R; Morgan A; Mullen A; Osborne A; Rageevakumar R; ; Kote-Jarai Z; Eeles R; Antoniou AC
Eur Urol; 2019 May; 75(5):834-845. PubMed ID: 30527799
[TBL] [Abstract][Full Text] [Related]
5. Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer.
Conran CA; Na R; Chen H; Jiang D; Lin X; Zheng SL; Brendler CB; Xu J
Asian J Androl; 2016; 18(4):520-4. PubMed ID: 27080480
[TBL] [Abstract][Full Text] [Related]
6. Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis.
Na R; Labbate C; Yu H; Shi Z; Fantus RJ; Wang CH; Andriole GL; Isaacs WB; Zheng SL; Helfand BT; Xu J
JAMA Netw Open; 2019 Dec; 2(12):e1918145. PubMed ID: 31880795
[TBL] [Abstract][Full Text] [Related]
7. Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial.
Chen H; Liu X; Brendler CB; Ankerst DP; Leach RJ; Goodman PJ; Lucia MS; Tangen CM; Wang L; Hsu FC; Sun J; Kader AK; Isaacs WB; Helfand BT; Zheng SL; Thompson IM; Platz EA; Xu J
Prostate; 2016 Sep; 76(12):1120-9. PubMed ID: 27197965
[TBL] [Abstract][Full Text] [Related]
8. Risk of prostate cancer in relatives of prostate cancer patients in Sweden: A nationwide cohort study.
Xu X; Kharazmi E; Tian Y; Mukama T; Sundquist K; Sundquist J; Brenner H; Fallah M
PLoS Med; 2021 Jun; 18(6):e1003616. PubMed ID: 34061847
[TBL] [Abstract][Full Text] [Related]
9. Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations.
Sun J; Chang BL; Isaacs SD; Wiley KE; Wiklund F; Stattin P; Duggan D; Carpten JD; Trock BJ; Partin AW; Walsh PC; Grönberg H; Xu J; Isaacs WB; Zheng SL
Prostate; 2008 Sep; 68(12):1257-62. PubMed ID: 18491292
[TBL] [Abstract][Full Text] [Related]
10. A comparison of genetic risk score with family history for estimating prostate cancer risk.
Helfand BT
Asian J Androl; 2016; 18(4):515-9. PubMed ID: 27004541
[TBL] [Abstract][Full Text] [Related]
11. Influence of IGFBP3 gene polymorphisms on IGFBP3 serum levels and the risk of prostate cancer in low-risk Korean men.
Park K; Kim JH; Jeon HG; Byun SS; Lee E
Urology; 2010 Jun; 75(6):1516.e1-7. PubMed ID: 20350746
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two methods for estimating absolute risk of prostate cancer based on single nucleotide polymorphisms and family history.
Hsu FC; Sun J; Zhu Y; Kim ST; Jin T; Zhang Z; Wiklund F; Kader AK; Zheng SL; Isaacs W; Grönberg H; Xu J
Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):1083-8. PubMed ID: 20332264
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer.
Setlur SR; Chen CX; Hossain RR; Ha JS; Van Doren VE; Stenzel B; Steiner E; Oldridge D; Kitabayashi N; Banerjee S; Chen JY; Schäfer G; Horninger W; Lee C; Rubin MA; Klocker H; Demichelis F
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):229-39. PubMed ID: 20056642
[TBL] [Abstract][Full Text] [Related]
14. A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry.
Darst BF; Wan P; Sheng X; Bensen JT; Ingles SA; Rybicki BA; Nemesure B; John EM; Fowke JH; Stevens VL; Berndt SI; Huff CD; Strom SS; Park JY; Zheng W; Ostrander EA; Walsh PC; Srivastava S; Carpten J; Sellers TA; Yamoah K; Murphy AB; Sanderson M; Crawford DC; Gapstur SM; Bush WS; Aldrich MC; Cussenot O; Yeager M; Petrovics G; Cullen J; Neslund-Dudas C; Kittles RA; Xu J; Stern MC; Kote-Jarai Z; Govindasami K; Chokkalingam AP; Multigner L; Parent ME; Menegaux F; Cancel-Tassin G; Kibel AS; Klein EA; Goodman PJ; Drake BF; Hu JJ; Clark PE; Blanchet P; Casey G; Hennis AJM; Lubwama A; Thompson IM; Leach R; Gundell SM; Pooler L; Xia L; Mohler JL; Fontham ETH; Smith GJ; Taylor JA; Eeles RA; Brureau L; Chanock SJ; Watya S; Stanford JL; Mandal D; Isaacs WB; Cooney K; Blot WJ; Conti DV; Haiman CA
Eur Urol; 2020 Sep; 78(3):316-320. PubMed ID: 32409115
[TBL] [Abstract][Full Text] [Related]
15. A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml.
Nordström T; Aly M; Eklund M; Egevad L; Grönberg H
Eur Urol; 2014 Jun; 65(6):1184-90. PubMed ID: 23891454
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of 5-alpha reductase inhibitors for the prevention of prostate cancer in multiple patient populations.
Earnshaw SR; McDade CL; Black LK; Bell CF; Kattan MW
Pharmacoeconomics; 2010; 28(6):489-505. PubMed ID: 20196623
[TBL] [Abstract][Full Text] [Related]
17. Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer.
Daugherty SE; Shugart YY; Platz EA; Fallin MD; Isaacs WB; Pfeiffer RM; Welch R; Huang WY; Reding D; Hayes RB
Prostate; 2007 Oct; 67(14):1487-97. PubMed ID: 17680641
[TBL] [Abstract][Full Text] [Related]
18. Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era.
Chen YC; Page JH; Chen R; Giovannucci E
Prostate; 2008 Oct; 68(14):1582-91. PubMed ID: 18646000
[TBL] [Abstract][Full Text] [Related]
19. Association of 8 loci on chromosome 8q24 with prostate carcinoma risk in northern Chinese men.
Zhao CX; Liu M; Wang JY; Xu Y; Wei D; Yang K; Yang Z
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6733-8. PubMed ID: 24377597
[TBL] [Abstract][Full Text] [Related]
20. Confirmation of a positive association between prostate cancer risk and a locus at chromosome 8q24.
Suuriniemi M; Agalliu I; Schaid DJ; Johanneson B; McDonnell SK; Iwasaki L; Stanford JL; Ostrander EA
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):809-14. PubMed ID: 17416775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
